The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and ...

The FTSE 100 finished down by 2.92%, or 231.05 points, to close at 7,679.48 – its lowest since March 2024. Major European ...

In New York, markets switched between red and green in volatile early trade. At the time of the London equities close, the DJIA was down 0.3%, the S&P 500 index was 0.2% lower, while the Nasdaq ...

London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled ...

Oil and pharmaceutical companies bore the brunt of heavy selling as the FTSE 100 index and other European bourses fell ...

ABL Bio Inc. sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier penetrating bispecific antibody platform, ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Britain will invest up to $767 million into a new health data research service to help boost scientific studies and cut the ...

Barclays cuts Pearson price target to 1,245 (1,330) pence - 'equal weight' Barclays raises Mondi to 'equal weight' (underweight) - price target 1,100 (1,110) pence Comments and questions to ...